ADIPOQ and metabolic dysfunction-associated steatotic liver disease: There was a significant increase in adiponectin concentration in the NAFLD (p = 0.006), NAFLD+LOLA (p = 0.003), and NAFLD+VitE (p = 0.001) groups compared with the control group.